Biocon Ltd. | BIOCON | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 10,572 | 9,986 | 20,154 | 17,475 | 24,001 |
Short-term investment |
| 8,293 | 8,576 | 12,609 | 12,177 | 13,265 |
Accounts receivables |
| 12,918 | 12,237 | 12,176 | 20,582 | 35,732 |
Inventories |
| 10,316 | 14,359 | 18,666 | 22,982 | 42,437 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Other current assets |
| 6,129 | 8,092 | 12,399 | 10,607 | 7,905 |
Total current assets |
| 48,228 | 53,250 | 76,004 | 83,823 | 123,340 |
Gross property plant... |
| 42,527 | 53,932 | 55,573 | 56,767 | 72,769 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 42,527 | 53,932 | 55,573 | 56,767 | 72,769 |
Work in Progress |
| 12,869 | 15,765 | 22,535 | 34,203 | 25,875 |
Miscellaneous Investment |
| 2,926 | 1,906 | 10,097 | 5,624 | 19,707 |
Deferred income taxes |
| 4,940 | 6,097 | 5,725 | 6,068 | 6,553 |
Intangible assets |
| 8,039 | 10,427 | 11,736 | 12,887 | 105,259 |
Goodwill |
| 264 | 264 | 264 | 264 | 161,362 |
Other long-term assets |
| 2,131 | 2,797 | 3,289 | 4,304 | 5,563 |
Total non-current assets |
| 73,696 | 91,188 | 109,219 | 120,117 | 397,088 |
Total assets |
| 121,924 | 144,438 | 185,223 | 203,940 | 520,428 |
Short-term debt |
| 2,612 | 6,676 | 5,942 | 9,055 | 24,802 |
Accounts Payable... |
| 11,983 | 13,251 | 15,139 | 16,085 | 39,831 |
Provisions |
| 805 | 1,030 | 1,094 | 1,305 | 1,486 |
Taxes Payable |
| 1,238 | 1,279 | 1,524 | 1,618 | 2,250 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 68 | 84 | 211 | 390 |
Other current liabilities |
| 13,738 | 17,776 | 18,318 | 10,006 | 16,348 |
Total current liabilities |
| 30,376 | 40,080 | 42,101 | 38,280 | 85,107 |
Long-term debt |
| 15,416 | 12,222 | 29,616 | 39,985 | 152,905 |
Investments Liabilities |
| 350 | 1,461 | 618 | 136 | 258 |
Deferred tax liabilities |
| 0 | 298 | 323 | 523 | 3,818 |
Provisions |
| 661 | 858 | 1,062 | 917 | 2,265 |
Capital Leases |
| 0 | 831 | 1,141 | 2,215 | 2,091 |
Other longterm liabilities |
| 8,052 | 14,857 | 25,286 | 27,184 | 49,096 |
Total non-current liabilities |
| 24,479 | 30,527 | 58,046 | 70,960 | 210,433 |
Total liabilities |
| 54,855 | 70,607 | 100,147 | 109,240 | 295,540 |
Share Capital |
| 3,000 | 6,000 | 6,000 | 6,003 | 6,003 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 57,980 | 61,058 | 70,269 | 78,322 | 172,666 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 6,089 | 6,773 | 8,807 | 10,375 | 46,219 |
Total Equity |
| 67,069 | 73,831 | 85,076 | 94,700 | 224,888 |
Total Liabilities and Equity |
| 121,924 | 144,438 | 185,223 | 203,940 | 520,428 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |